2 procedures tracked
Amendment to Regulation (EC) No 273/2004 (+1 more)
2026/2619(DEA)
Subjecting the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide
2017/0152(NLE)